NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE130269 Query DataSets for GSE130269
Status Public on Apr 24, 2019
Title Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 31969702
Submission date Apr 24, 2019
Last update date Feb 19, 2020
Contact name Xin Lu
E-mail(s) xin.x.lu@abbvie.com
Phone 847-937-7942
Organization name Abbvie
Department Oncology Discovery
Street address 1 North Waukegan Rd
City North Chicago
State/province IL
ZIP/Postal code 60064
Country USA
 
Platforms (1)
GPL21290 Illumina HiSeq 3000 (Homo sapiens)
Samples (20)
GSM3319568 LNCaP_EtOH_DMSO rep1
GSM3319569 LNCaP_EtOH_DMSO rep2
GSM3319570 LNCaP_DHT_DMSO rep1
This SuperSeries is composed of the following SubSeries:
GSE118152 Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq)
GSE130247 Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq)
Relations
BioProject PRJNA534480

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary data files not provided
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap